Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 4,860,000 shares, a drop of 6.5% from the March 31st total of 5,200,000 shares. Based on an average daily volume of 2,140,000 shares, the short-interest ratio […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Average Recommendation of "Hold" by Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Average Recommendation of "Hold" from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 7,920,000 shares, a drop of 8.3% from the February 29th total of 8,640,000 shares. Based on an average trading volume of 2,210,000 shares, […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 7,920,000 shares, a decline of 8.3% from the February 29th total of 8,640,000 shares. Based on an average daily volume of 2,210,000 shares, the short-interest ratio […]